333.31 g/mol Purity 98% CAS No
The Lancet+1 Pros of observational data: large numbers, real world
Who Is Generally Excluded FDA labels list contraindications and precautions that typically rule out or require caution with GLP-1 therapy: Personal or family history of medullary thyroid carcinoma Multiple endocrine neoplasia syndrome type 2 (MEN 2) Known hypersensitivity to the drug History of pancreatitis (caution, not absolute contraindication) Active gallbladder disease (caution) Severe gastroparesis or other significant GI motility disorders Pregnancy or planning pregnancy (discontinuation typically recommended) Type 1 diabetes (not studied for this indication) Additionally, patients with severe kidney or liver disease, those on certain medications that affect insulin or GI motility, and those with eating disorders should have careful evaluation
Similar to pregnancy, researchers dont have enough data on how these treatments affect breastfed babies
In May, Omada launched its GLP-1 Care Track for the first time
-Ketoglutarate may contribute to the restoration of ovarian reserve and improve pregnancy rates in a CTX-induced POI rat model, potentially by inhibiting Caspase-3 activity (Li T
